Search by Drug Name, NDC or Jcode

    Internal Navigation

    HCPCS Details

    HCPC J1325
    Short Description Epoprostenol injection
    Long Description Injection, epoprostenol, 0.5 mg
    Pricing indicator 51
    Coverage code D
    ASC payment group code
    BETOS2 code O1E
    Action code N
    Type of service 1
    Effective date 1998-01-01
    Date Added 1998-01-01

    HCPCS/NDC Cross-Walk

    NDC HCPC Description Drug Name Labeler Name HCPCS Dosage PKG Size PKG QTY Bill Units Bill Units PKG
    00173051700 J1325 Epoprostenol injection Flolan GLAXOSMITHKLINE 0.5 MG 1 1 1 1
    00173051900 J1325 Epoprostenol injection Flolan GLAXOSMITHKLINE 0.5 MG 1 1 3 3
    00703198501 J1325 Epoprostenol injection Epoprostenol SICOR PHARMACEUTICALS, INC. 0.5 MG 1 1 1 1
    00703199501 J1325 Epoprostenol injection Epoprostenol SICOR PHARMACEUTICALS, INC. 0.5 MG 1 1 3 3
    62756005940 J1325 Epoprostenol injection Epoprostenol SUN PHARMACEUTICAL INDUSTRIES, LTD. 0.5 MG 1 1 1 1
    62756006040 J1325 Epoprostenol injection Epoprostenol SUN PHARMACEUTICAL INDUSTRIES, LTD. 0.5 MG 1 1 3 3
    66215040201 J1325 Epoprostenol injection Epoprostenol (Veletri) ACTELION PHARMACEUTICALS US, INC. 0.5 MG 1 1 3 3
    66215040301 J1325 Epoprostenol injection Epoprostenol (Veletri) ACTELION PHARMACEUTICALS US, INC. 0.5 MG 1 1 1 1
    The ASP crosswalks are maintained by the Division of Data Analysis and Market Based Pricing to support ASP-based Medicare Part B payments only. The crosswalks are intended to help the public (including entities that submit manufacturer ASP data and providers who bill for drugs) understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes. The crosswalks are not intended to be a comprehensive list of all drugs/NDCs available in the United States. The NDC to HCPCS Crosswalk also includes information on the NDC package size and the number of billable units (as defined by the HCPCS code descriptor). Comments on the file may be sent to [email protected].

    Drug Details

    • Epoprostenol injection is used to treat certain kinds of pulmonary arterial hypertension (PAH; high blood pressure in the vessels carrying blood to the lungs, causing shortness of breath, dizziness, and tiredness). Epoprostenol may improve the ability to exercise and slow the worsening of symptoms in patients with PAH. Epoprostenol is in a class of medications called vasodilators and platelet-aggregation inhibitors. It works by relaxing the blood vessels, including those in the lungs, and improving blood flow.